Aitor Maestro1, Sebastien Lemaire2, Syuzanna R Harutyunyan1. 1. Stratingh Institute for Chemistry, University of Groningen, 9747 AG Groningen,The Netherlands. 2. Janssen Pharmaceutica, Chemical Process Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium.
Abstract
Herein we report the first alkynylation of quinolones with terminal alkynes under mild reaction conditions. The reaction is catalyzed by Cu(I) salts in the presence of a Lewis acid, which is essential for the reactivity of the system. The enantioselective version of this transformation has also been explored, and the methodology has been applied in the synthesis of the enantioenriched tetrahydroquinoline alkaloid cuspareine.
Herein we report the first alkynylation of quinolones with terminal alkynes under mild reaction conditions. The reaction is catalyzed by Cu(I) salts in the presence of a Lewis acid, which is essential for the reactivity of the system. The enantioselective version of this transformation has also been explored, and the methodology has been applied in the synthesis of the enantioenriched tetrahydroquinoline alkaloid cuspareine.
Quinolone (A) derivatives
such as ciprofloxacin B are well known as broad-spectrum
bacteriocidal agents[1−6] (Figure ), which
consequently has prompted the development of several methods for their
synthesis.[7−9] However, molecules with abundant sp3 carbons
in their structure, such as dihydroquinolone derivatives, are becoming
increasingly attractive for the development of potential drug candidates.[10] In this context,
dihydroquinolone derivative C has been reported as a
5-HT6 serotonin receptor,[11] and other dihydroquinolones
have been shown to be applicable as crucial intermediates in the production
of martinellic acid D(12−14) and (+)-angustureine E.[15−17] Therefore, the development of new efficient methodologies
for the synthesis of dihydroquinolones would improve the chemical
toolbox for the synthesis of biologically relevant molecules.
Figure 1
Relevant quinolones
and their derivatives.
Relevant quinolones
and their derivatives.During the last couple
of decades, several examples of dihydroquinoline
synthesis based on the functionalization of quinolones have been reported.
These quinolone functionalizations, including Pd- and Rh-catalyzed
arylations (Scheme a)[18−20] and, more recently, Cu(I)-catalyzed alkylations using
organomagnesium and organoaluminum reagents (Scheme b),[15,21] afford 4-oxo-2,3-dihydroquinolines.
Despite this progress with arylations and alkylations, alkynylations
of quinolones have not been reported. We were interested in exploring
alkynylation reactions of quinolones to extend the structural variety
of functionalized dihydroquinolones. The synthesis of two alkynylated
4-oxo-2,3-dihydroquinolines has been previously described,[22,23] making use of 4-alkoxyquinolines and alkynylmagnesium bromides or
organozinc chlorides as nucleophiles in a lengthy multistep procedure.
The limited scope of readily available alkynylmagnesium bromides and
the lengthy multistep procedure limit the potential of this method.
Scheme 1
Functionalization of 4-Quinolones: (a) Arylation, (b) Alkylation,
and (c) Alkynylation (This Work)
On the contrary, the use of readily available and structurally
diverse terminal alkynes as pronucleophiles, along with the mild reaction
conditions, offers an attractive strategy for the synthesis of structurally
diverse quinolone derivatives. Several examples of this approach,
including Cu(I)-catalyzed alkynylations of (thio)chromones[24−27] and quinolines[13,28] and allylic alkylations of terminal
alkynes,[29] have been published during the
last several years, but the direct Cu(I)-catalyzed alkynylation of
quinolones has not been accomplished so far.[30,31]Herein we report the first example of the direct Cu(I)-catalyzed
alkynylation of 4-quinolones with terminal alkynes as pronucleophiles
(Scheme c). This methodology
offers a new path for functionalizing quinolones with an alkynyl moiety
that complements the existing synthetic routes toward 4-oxo-2,3-dihydroquinolines.At the start of this work, the optimization studies were carried
out for the alkynylation reaction between Cbz-protected quinolone 1a and phenylacetylene 2a in the presence of
base DIPEA and catalytic amounts of Cu(I) salt. On the basis of our
group’s experience with Lewis-acid-promoted Cu(I)-catalyzed
conjugate additions,[15,32−35] we evaluated the effect of several
Lewis acids to enhance the electrophilicity of the quinolone substrate 1a. Excellent conversion to the desired addition product 3a was observed in the presence of a stoichiometric amount
of tert-butyldimethylsilyl triflate (TBDMSOTf) after
stirring overnight (Table , entry 1). Shortening the reaction time to 4 h had little
effect on the substrate conversion (entry 2). Further optimization
of the solvent and the base (see the Supporting Information) confirmed the conditions in entry 1 as the most
optimal. Next, we evaluated the effect of the protecting group of
the quinolone substrate on the reaction outcome.
Conversion
was determined by 1H NMR with respect to the quinolone.
No CuI was used.
20 mol % of LA was used.
Reaction
conditions: quinolone 1 (0.1 mmol), CuI (10 mol %), toluene
(1 mL), alkyne 2a (1.3 equiv), DIPEA (1.6 equiv), LA
(1.2 equiv).Conversion
was determined by 1H NMR with respect to the quinolone.No CuI was used.20 mol % of LA was used.No conversion was observed when
unprotected or benzyl-protected
quinolones were used (entries 3 and 4). Moreover, replacing the Cbz
protecting group on the quinolone substrate by a Boc group resulted
in a significant drop in the conversion (entry 5). Further studies
confirmed that the presence of a copper salt and a stoichiometric
amount of a Lewis acid are mandatory to promote the reaction to completion.
No conversion of quinolone was observed in the absence of copper salt
or using only a catalytic amount of a Lewis acid (entries 6–8).
With silyl-based Lewis acids other than TBDMSOTf, a lower substrate
conversion was obtained (entries 9–13). Only traces of the
addition product 3a were obtained when trimethylsilyl
halides were used instead (entries 9 and 10). The use of stronger
silicon-based Lewis acids such as trimethylsilyl (TMS) and triethylsilyl
(TES) triflates resulted in moderate reaction rates (entries 11 and
12), whereas the boron-based Lewis acid BF3·Et2O did not improve the reaction outcome either (entry 13).
The superiority of TBDMSOTf over other explored silyl triflates can
be rationalized by the higher stability of a possible TBDMS-enolate
intermediate formed during the reaction.Having the optimized
conditions in hand (entry 1), we moved to
study the scope of the reaction. For this purpose, various alkynes
and quinolones were tested (Scheme ).
Reaction conditions:
quinolone 1 (0.1 mmol), CuI (10 mol %), toluene (1 mL),
alkyne 2 (1.3 equiv), DIPEA (1.6 equiv), TBDMSOTf (1.2
equiv).The reaction was successfully extended
to several aromatic terminal
alkynes bearing electron-donating and electron-withdrawing groups
and four-, three-, and two-substituted aromatic rings (3ab–3aj). An excellent yield was also obtained with
heteroaromatic alkyne 3ak. Similar results were obtained
when using cyclopropyl-, isobutyl-, and ester-substituted alkynes
(3al–3an). Surprisingly, the linear
terminal alkyne 1-pentyne was unreactive under the optimized reaction
conditions (3ao). The limited reactivity of alkyl alkynes
and the lack of reactivity of linear alkynes are consistent with the
literature observations in other Cu-catalyzed reactions.[31,36,37] Various quinolones can be used
with this catalytic system. Excellent yields were obtained for quinolones
both with activating and with deactivating groups present in the quinolone
ring (3eg–3ig) and for those with
disubstituted substrates (3jg and 3kg).Next, we envisaged that the use of a copper salt in combination
with a chiral ligand could lead to enantioinduction through the binding
of the chiral copper complex to the quinolone. After some optimization,
we found that the copper complex of chiral diphenylphosphine ligand
BPE catalyzes the alkynylation of several quinolone substrates with
enantioselectivities in the range of 50–82% ee (Scheme ), thus confirming the feasibility
of the catalytic asymmetric synthesis of these molecules.
Scheme 3
Enantioselective
Alkynylation of Quinolones
Reaction conditions: quinolone 1a (0.1 mmol), CuI (10 mol %), I (11 mol %),
toluene (1 mL), alkyne 2 (1.3 equiv), DIPEA (1.6 equiv),
TBDMSOTf (1.2 equiv). ee values were determined by chiral high-performance
liquid chromatography (HPLC) or supercritical fluid chromatography
(SFC).
Enantioselective
Alkynylation of Quinolones
Reaction conditions: quinolone 1a (0.1 mmol), CuI (10 mol %), I (11 mol %),
toluene (1 mL), alkyne 2 (1.3 equiv), DIPEA (1.6 equiv),
TBDMSOTf (1.2 equiv). ee values were determined by chiral high-performance
liquid chromatography (HPLC) or supercritical fluid chromatography
(SFC).The robustness of the methodology was
tested by scaling up the
synthesis of 3aa to 1 mmol (Scheme ). Moreover, the selective deprotection of
the Cbz group was successfully performed under basic conditions to
afford dihydroquinolin-4-one 4 in 83% yield.
Scheme 4
Scaling
Up and Synthetic Applications of Quinolone Derivatives 3
The hydrogenation of 3ap with Pd on activated carbon
under acidic conditions followed by the methylation of the nitrogen
atom afforded the Hancock alkaloid (+)-cuspareine (5)
without racemization, allowing the determination of the absolute configuration
of the stereogenic carbon by comparing the optical rotation of cuspareine
with literature data.[16,17]In summary, an efficient
methodology for the alkynylation of quinolones
with readily available terminal alkynes has been accomplished. This
methodology tolerates the presence of several functional groups in
both the quinolone and alkyne reagents and complements the previously
developed arylation and alkylation reactions of quinolones. We have
also demonstrated the feasibility of an enantioselective version and
applied the current methodology to the synthesis of the enantioenriched
Hancock alkaloid (+)-cuspareine. Further studies are under way, aiming
to improve the enantioselective variant and shed light on the underlying
mechanism.
Authors: Michael R Luzung; Darryl D Dixon; Adrian Ortiz; Carlos A Guerrero; Sloan Ayers; Jeanne Ho; Michael A Schmidt; Neil A Strotman; Martin D Eastgate Journal: J Org Chem Date: 2017-09-07 Impact factor: 4.354
Authors: Chul Min Park; Jin Il Choi; Jung Hwan Choi; So Young Kim; Woo Kyu Park; Churl Min Seong Journal: Bioorg Med Chem Lett Date: 2010-12-08 Impact factor: 2.823
Authors: Steven K Korang; Mathias Maagaard; Joshua B Feinberg; Anders Perner; Christian Gluud; Janus C Jakobsen Journal: Acta Anaesthesiol Scand Date: 2021-04-16 Impact factor: 2.105
Authors: Stephen G Davies; Ai M Fletcher; Ian T T Houlsby; Paul M Roberts; James E Thomson; David Zimmer Journal: J Nat Prod Date: 2018-11-20 Impact factor: 4.050